Showing 1 to 10 of 13 clinical trials
1 | 2 |
CLINICAL TRIALS
    Trial No
    ClinicalTrials.gov ID
Phase Coordinator
Improving Outcomes in Patients With Hepatobiliary and Pancreatic Cancers With a Nutritional and Physical Conditioning Prehabilitation Program
    prehab_pilot
    NCT03475966
     Recruiting
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer
    PAC.3 (A021806)
    NCT04340141
     Recruiting
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
Jacqueline Lewis
514-934-1934 poste 34909
Diagnostic Value of Diffusion-weighted Magnetic Resonance Imaging for Detection of Peritoneal Metastases in High-risk Pancreatic Ductal Adenocarcinoma: a Pilot Study.
    2022-6186
    NCT05340569
     Recruiting
CHU DE QUEBEC – UNIVERSITE LAVAL
HOPITAL DE L'ENFANT-JESUS
A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer
    PAC.3 (A021806)
    NCT04340141
     Recruiting
CHU DE QUEBEC – UNIVERSITE LAVAL
HOPITAL DE L'ENFANT-JESUS
Mélanie Croussette
418-525-4444 poste 22637
A Randomized Controlled Trial of Endoscopic Ultrasound Guided Celiac Plexus Neurolysis (EUS-CPN) With and Without Bupivacaine
    21.151
    NCT04951804
     Recruiting
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
Charles Mackay
514-890-8000 poste 36484
A Phase 1 Feasibility Study of Cholesterol Metabolism Disruption (Evolocumab, Atorvastatin and Ezetimibe) in Combination With FOLFIRINOX in Patients With Metastatic Pancreatic Adenocarcinoma
    CHLOE
    NCT04862260
     Recruiting
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
Adeline Hamon
514-890-8000 poste 30737
A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters on Advanced Pancreatic Cancer
    AT-PANC-101
    NCT04002479
     Recruiting
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
Adeline Hamon
514-890-8000 poste 30737
A Phase II, Open-Label, Multicenter, Randomized Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Patients With Resected Pancreatic Ductal Adenocarcinoma
    IMCODE003 (GO44479)
    NCT05968326
     Recruiting
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
Chantal Gosselin
514-890-8000 poste 24892
A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer
    PAC.3 (A021806)
    NCT04340141
     Recruiting
CIUSSS DE L'ESTRIE – CENTRE HOSP. UNIV. DE SHERBROOKE
HOPITAL FLEURIMONT
Michelle Roy
819-346-1110 poste 12848
A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters on Advanced Pancreatic Cancer
    AT-PANC-101
    NCT04002479
     Recruiting
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL
HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS
Pricille Cleveaux
514-340-8222 poste 24480
1 | 2 |